GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: compound 11c [PMID: 2617910] | Ro 09-4889
Compound class:
Synthetic organic
Comment: RO0094889 is a prodrug dihydropyrimidine dehydrogenase (DPD) inhibitor that was developed by Hoffmann-La Roche [3]. RO0094889 is metabolised by enzymes secreted by tumours to produce the DPD inhibitor 5-vinyluracil. This leads to inhibition of DPD-mediated catabolic degradation of the 5-fluorouracil produced locally in tumours from capecitabine [2]. RO0094889 is orally active.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| [(2R,3R,4R,5R)-4-acetyloxy-5-(4-amino-5-ethenyl-2-oxopyrimidin-1-yl)-2-methyloxolan-3-yl] acetate |
Synonyms ![]() |
| compound 11c [PMID: 2617910] | Ro 09-4889 |
Database Links ![]() |
|
| GtoPdb PubChem SID | 387065596 |
| PubChem CID | 9840745 |
| Search Google for chemical match using the InChIKey | NELWQUQCCZMRPB-UBPLGANQSA-N |
| Search Google for chemicals with the same backbone | NELWQUQCCZMRPB |
| UniChem Compound Search for chemical match using the InChIKey | NELWQUQCCZMRPB-UBPLGANQSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | NELWQUQCCZMRPB-UBPLGANQSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖